Edgewise Therapeutics Inc. Common Stock vs Macerich Company (The) Common Stock — how do they compare? Edgewise Therapeutics Inc. Common Stock trades at $37.32 (market cap $3.94B), while Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B). The key difference: Macerich Company (The) Common Stock is the larger of the two by market cap, and Macerich Company (The) Common Stock pays a 3.02% dividend while Edgewise Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Edgewise Therapeutics Inc. Common Stock for 0 Days and Macerich Company (The) Common Stock for 0 Days on average.
| EWTX | MAC | |
|---|---|---|
Market Cap | $3.94B | $6.39B |
Volume | 810,104 | 2,684,151 |
Sector | Health | Real Estate |
52-Week High | $48.35 | $26.51 |
52-Week Low | $14.89 | $16.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.48B | $11.07B |
Dividend Yield | — | 3.02% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Edgewise Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops small-molecule therapies based on its research in muscle physiology, with a pipeline focused on cardiovascular and cardiometabolic conditions such as hypertrophic cardiomyopathy and heart failure.
Read more on EWTX →The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.
Read more on MAC →